Theratechnologies Inc. (THTX)
NASDAQ: THTX · Real-Time Price · USD
1.400
+0.065 (4.64%)
At close: Apr 1, 2025, 4:00 PM
1.411
+0.011 (0.78%)
After-hours: Apr 1, 2025, 4:48 PM EDT
Theratechnologies Employees
Theratechnologies had 103 employees as of November 30, 2023. The number of employees decreased by 41 or -28.47% compared to the previous year.
Employees
103
Change (1Y)
-41
Growth (1Y)
-28.47%
Revenue / Employee
$833,650
Profits / Employee
-$80,641
Market Cap
65.90M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
THTX News
- 6 days ago - Theratechnologies Receives FDA Approval for EGRIFTA WR™ (Tesamorelin F8) to Treat Excess Visceral Abdominal Fat in Adults with HIV and Lipodystrophy - GlobeNewsWire
- 20 days ago - Theratechnologies Presents Encouraging Virologic Suppression Data from the PROMISE-US Trial of Ibalizumab at CROI - GlobeNewsWire
- 20 days ago - Theratechnologies CROI Presentation Highlights Limitations of Using BMI to Assess Cardiovascular (CV) Risk in People with HIV - GlobeNewsWire
- 4 weeks ago - Theratechnologies Inc. (THTX) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - Theratechnologies Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2024 - GlobeNewsWire
- 6 weeks ago - Theratechnologies to Announce Fourth Quarter and Full Year 2024 Financial Results and Provide Business Update - GlobeNewsWire
- 6 weeks ago - Theratechnologies Resumes Distribution of EGRIFTA SV® - GlobeNewsWire
- 2 months ago - Theratechnologies Provides Update on EGRIFTA SV® Supply - GlobeNewsWire